en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu

CyberKnife® for Brain Tumors

CyberKnife robotic stereotactic radiosurgery (SRS) painlessly delivers precise beams of high-dose radiation to brain tumors and lesions, without incisions, hospitalization, or long recovery time. CyberKnife SRS is a non-invasive alternative to brain cancer surgery and can be used for brain tumors that are considered inoperable because of their location in the head, for those patients who cannot undergo brain cancer surgery due to their poor medical condition, or who refuse surgery. The CyberKnife System also can treat benign, or non-cancerous, tumors and other conditions, such as trigeminal neuralgia and arteriovenous malformations (AVMs).

BRAIN CANCER BEFORE AND AFTER TREATMENT WITH CYBERKNIFE

Pre-Treatment

Post-Treatment

82 year old female treated for breast cancer in 2007 and 2012. Follow-up in 2012 she presented with brain metastasis in the right frontal and left occipital parietal lobes and was treated with SRS. The patient developed an additional metastases in her left occipital lobe in 2013, also treated with SRS. The patient then went on to develop subsequent metastases in the right temporal and the left medial cerebellum in February and March of 2014. These new lesions again received SRS treatment. The MRI used for this most recent treatment plan showed the 2 previously treated frontal lesions completely resolved.

Brain Tumor Types

  • Acoustic Neuroma
  • Anaplastic Astrocytoma
  • Brain Metastases
  • Chordoma
  • Craniopharyngioma
  • Ependymoma
  • Gangliocytoma
  • Germinoma
  • Glioblastoma Multiforme
  • Glioma
  • Glomus Tumors
  • Hemangioblastoma
  • Meningioma
  • Neurocytoma
  • Neurofibroma
  • Neurofibromatosis
  • Oligodendroglioma
  • Parotid SCCA
  • Pituitary Adenoma
  • Schwannoma
  • Skull Base Tumors
  • Vestibular Schwannoma

Key Advantages of CyberKnife for Brain Tumors

  • Non-invasive, no incisions, painless
  • No anesthesia or hospitalization required
  • Treats patients in 5 or fewer visits
  • Reaches tumors from virtually unlimited directions with robotic mobility
  • Enables clinicians to maximize and conform the dose to the tumor target
  • Constantly tracks tumor movement throughout treatment
  • Pinpoint Accuracy
  • Few side effects and minimal radiation exposure to healthy tissue surrounding the tumor
  • Immediate return to daily activities

Patient Resource Tools

Speak with one of our dedicated Team Member about how we can help today.